BUE Equity Snapshot

AMGN Weekly Equity Report

Amgen Inc.

Interactive chart JSON snapshot
Latest Close 17,750 ARS 12 Jun 2026
1W Return 0.6% latest completed week
4W Return 9.9% short-term follow-through
12W Return 4.9% quarterly tape
Trend Breadth 82.7% 43 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
Company Brief

What the company does

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number …

Snapshot

What the weekly tape is saying

AMGN closed the latest completed week at 17,750 ARS. The 4-week return is 9.9% and the 12-week return is 4.9%. Trend Signal is inactive, Market Dynamics is -0.72. Setup signature: Balanced read with a 44/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend 2.9%
Volume 0.8x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 45 Persistence of active Trend Signal over the last year and current streak.
Momentum 77 Blend of 4-week and 12-week follow-through.
Dynamics 39 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 33 Participation compared with the 13-week volume baseline.
Risk Control 70 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
17,250 ARS
Vs Trend Line
2.9%
Fair Value
15,212 ARS
Vs Fair Value
16.7%
52W High
19,280 ARS
52W Low
10,625 ARS
Drawdown
-7.9%
Range Position
82.3%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 0.6%
4W 9.9%
12W 4.9%
26W 11.1%
52W 52.0%

Trend read

Active Streak
0 weeks
52W Active Weeks
43
52W Active Breadth
82.7%
Sector Scope
AR Healthcare
Sector Rank
7 of 20
Sector Percentile
68.4%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.72
4W MD Change
27.9%
Relative Strength
-13.91
4W RS Change
-463.7%
Expectation
Positive
Probability
57.69%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
6.1K
13W Average
7.8K
52W Average
11.0K
Vs 13W
0.8x
Vs 52W
0.6x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
3.1%
52W Volatility
4.7%
Upside Weeks
29
Downside Weeks
23
Downside Breadth
44.2%
Avg Gain / Loss
4.0% / -2.9%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
BUE
Country
AR
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
ARS
Market Cap
1772.4B

Opportunity signals

  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Market Dynamics is negative, which weakens the current setup.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 17,750 ARS 0.6% 17,250 ARS 15,212 ARS -0.72 -13.91 6.1K Off
5 Jun 2026 17,640 ARS 5.9% 17,218 ARS 15,173 ARS -0.96 -7.06 9.0K Off
29 May 2026 16,660 ARS -0.8% 17,153 ARS 15,130 ARS -1.08 -14.40 2.1K Off
22 May 2026 16,800 ARS 4.0% 17,095 ARS 15,093 ARS -1.04 -3.91 30.2K Off
15 May 2026 16,150 ARS -1.8% 17,042 ARS 15,055 ARS -1.00 -2.47 4.9K Off
8 May 2026 16,440 ARS -5.0% 17,016 ARS 15,022 ARS -0.93 -2.50 8.4K Off
1 May 2026 17,310 ARS 0.3% 16,949 ARS 14,987 ARS -0.91 0.70 3.9K On
24 Apr 2026 17,260 ARS -0.2% 16,878 ARS 14,945 ARS -0.88 0.31 18.2K On
17 Apr 2026 17,290 ARS 0.1% 16,748 ARS 14,904 ARS -1.05 -0.87 5.7K On
10 Apr 2026 17,270 ARS -1.2% 16,668 ARS 14,863 ARS -1.11 -4.33 5.1K On
3 Apr 2026 17,480 ARS 2.1% 16,546 ARS 14,818 ARS -0.78 -3.16 1.4K On
27 Mar 2026 17,120 ARS 1.2% 16,402 ARS 14,772 ARS -0.47 1.70 2.3K On
20 Mar 2026 16,920 ARS -5.9% 16,263 ARS 14,725 ARS -0.05 3.20 3.7K On
13 Mar 2026 17,990 ARS -0.3% 16,135 ARS 14,675 ARS 0.14 13.41 16.0K On